ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO934

Comparison of the Expression Levels of Senescence Genes between Human Normal Kidney Cells and Kidney Tumor Cells According to Age

Session Information

Category: Geriatric Nephrology

  • 1300 Geriatric Nephrology

Authors

  • Park, Woo Yeong, Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea (the Republic of)
  • Kim, Yaerim, Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea (the Republic of)
  • Paek, Jin hyuk, Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea (the Republic of)
  • Jin, Kyubok, Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea (the Republic of)
  • Han, Seungyeup, Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea (the Republic of)
Background

Although most carcinogenic mutations induce senescence, senescence-induced cell-cycle arrest can prevent mutations, resulting in the suppression of tumorigenesis. On the contrary, the senescence-associated secretory phenotype also contributes to a pro-inflammatory and growth-stimulatory microenvironment that can promote tumor development. Despite their potential correlation, the relationship between tumor- and aging-related transcriptional changes is largely unknown.

Methods

We integrated three datasets in publicly available bulk and single-cell RNA-seq: Gene Expression Omibus (GSE207493, GSE159115, GSE131685), and applied new senescent gene set in CellAge and SenMayo to our dataset. We classified them into younger and older age groups to compare senescent gene expression patterns in normal kidney and kidney tumor cells based on the age. The study aims to investigate the differences in expression patterns of senescence genes between them.

Results

We clustered normal kidney and kidney tumor cells in the UMAP plot. Kidney tumor was located on the proximal tubule. We compared senescent gene expression levels between normal kidney and kidney tumor cells, focusing on differences between younger and older age groups. ACTB and GAPDH were in the control group, and the expression of representative senescent genes p21 (CDKN1A), p16 (CDKN2A), and p53 (TP53) was confirmed. Among them, the expression difference in CDKN1A was found to be greater in kidney tumor cells than in normal kidney cells. I applied the new senescent gene set, and CTSS, G0S2, S100A11, NEAT1, and SERPINA1 showed similar patterns. This suggests that in kidney tumors, the difference in expression of senescent genes becomes greater with older age.

Conclusion

Kidney tumorigenesis might be associated with senescent genes. This result can serve as a basis for future studies on the role of aging and senescence in human kidney malignancies.

The difference of senescent gene expression between younger and older age in normal kidney cells and kidney tumor cells

Funding

  • Government Support – Non-U.S.